| 1 |
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
Jennifer M. Burns, Bretton C. Summers, Yu Wang et al. · The Journal of Experimental Medicine
Open access |
28 Aug 2006 |
1,280 |
| 2 |
Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis
Bi‐Sen Ding, Zhongwei Cao, Raphaël Lis et al. · Nature
Open access |
19 Nov 2013 |
632 |
| 3 |
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
David R.W. Jayne, Annette N. Bruchfeld, Lorraine Harper et al. · Journal of the American Society of Nephrology
Open access |
11 Apr 2017 |
610 |
| 4 |
A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
Laura R. Saunders et al. · Science Translational Medicine
Open access |
26 Aug 2015 |
606 |
| 5 |
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
Charles M. Rudin et al. · The Lancet Oncology
Open access |
5 Dec 2016 |
578 |
| 6 |
CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature
Zhenhua Miao, Kathryn E. Luker, Bretton C. Summers et al. · Proceedings of the National Academy of Sciences
Open access |
26 Sep 2007 |
539 |
| 7 |
Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo
Santiago Partida‐Sánchez, Debra A. Cockayne, Simon P. Monard et al. · Nature Medicine
|
Nov 2001 |
455 |
| 8 |
C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN
Hong Xiao, Daniel J. Dairaghi, Jay P. Powers et al. · Journal of the American Society of Nephrology
Open access |
Nov 2013 |
361 |
| 9 |
CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas
Joseph Flores‐Toro, Defang Luo, Adithya Gopinath et al. · Proceedings of the National Academy of Sciences
Open access |
26 Dec 2019 |
345 |
| 10 |
Cytomegalovirus encodes a potent α chemokine
Mark E.T. Penfold, Daniel J. Dairaghi, Gregory M. Duke et al. · Proceedings of the National Academy of Sciences
Open access |
17 Aug 1999 |
336 |
| 11 |
Overcoming hurdles in developing successful drugs targeting chemokine receptors
Thomas J. Schall, Amanda E. I. Proudfoot · Nature reviews. Immunology
Review |
15 Apr 2011 |
325 |
| 12 |
Potent Immunosuppressive Activities of Cytomegalovirus- Encoded Interleukin-10
Juliet V. Spencer, Kristen M. Lockridge, Peter A. Barry et al. · Journal of Virology
Open access |
Feb 2002 |
320 |
| 13 |
The Chemokine Receptor CXCR7 Is Highly Expressed in Human Glioma Cells and Mediates Antiapoptotic Effects
Kirsten Hattermann, Janka Held‐Feindt, Ralph Lucius et al. · Cancer Research
|
13 Apr 2010 |
314 |
| 14 |
Elucidation of CXCR7-Mediated Signaling Events and Inhibition of CXCR4-Mediated Tumor Cell Transendothelial Migration by CXCR7 Ligands
Brian A. Zabel, Yu Wang, Susanna Lewén et al. · The Journal of Immunology
Open access |
29 Jul 2009 |
296 |
| 15 |
The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial
Dick de Zeeuw, Pirow J. Bekker, Elena Henkel et al. · The Lancet Diabetes & Endocrinology
|
9 Aug 2015 |
281 |
| 16 |
CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity
Lillian Cruz‐Orengo, David W. Holman, Denise A. Dorsey et al. · The Journal of Experimental Medicine
Open access |
7 Feb 2011 |
230 |
| 17 |
Cutting Edge: Identification of a Novel Chemokine Receptor That Binds Dendritic Cell- and T Cell-Active Chemokines Including ELC, SLC, and TECK
Jennifa Gosling, Daniel J. Dairaghi, Yu Wang et al. · The Journal of Immunology
|
Mar 2000 |
208 |
| 18 |
Evidence for NK Cell Subsets Based on Chemokine Receptor Expression
Robert Berahovich, Nicholas Lai, Zheng Wei et al. · The Journal of Immunology
Open access |
Dec 2006 |
191 |
| 19 |
HHV8-encoded vMIP-I Selectively Engages Chemokine Receptor CCR8
Daniel J. Dairaghi, Rong A. Fan, Brian E. McMaster et al. · Journal of Biological Chemistry
Open access |
Jul 1999 |
190 |
| 20 |
Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century
Samuel A. Williams, Wade C. Anderson, Marianne T. Santaguida et al. · Laboratory Investigation
Open access |
5 Aug 2013 |
187 |
| 21 |
Neuronal Fractalkine Expression in HIV-1 Encephalitis: Roles for Macrophage Recruitment and Neuroprotection in the Central Nervous System
Ning Tong, Seth W. Perry, Qing Zhang et al. · The Journal of Immunology
Open access |
Feb 2000 |
186 |
| 22 |
Proteolytic Activation of Alternative CCR1 Ligands in Inflammation
Robert Berahovich, Zhenhua Miao, Yu Wang et al. · The Journal of Immunology
Open access |
Jun 2005 |
184 |
| 23 |
A review of genetic differences between limited and extensively passaged human cytomegalovirus strains
Mark N. Prichard, Mark E.T. Penfold, Greg M. Duke et al. · Reviews in Medical Virology
|
May 2001 |
176 |
| 24 |
Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation
Elektra J. Papadopoulos, Chris Sassetti, Hidehisa Saeki et al. · European Journal of Immunology
Open access |
Aug 1999 |
170 |
| 25 |
Cancer associated fibroblast FAK regulates malignant cell metabolism
Fevzi Demircioglu et al. · Nature Communications
Open access |
10 Mar 2020 |
169 |
| 26 |
Cytomegalovirus-encoded β chemokine promotes monocyte-associated viremia in the host
Noah Saederup, Yu Lin, Daniel J. Dairaghi et al. · Proceedings of the National Academy of Sciences
Open access |
14 Sep 1999 |
164 |
| 27 |
Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease
Matthew J. Walters, Yu Wang, Nicholas Lai et al. · Journal of Pharmacology and Experimental Therapeutics
|
22 Jul 2010 |
160 |
| 28 |
Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study
Pirow J. Bekker, Daniel J. Dairaghi, Lisa C. Seitz et al. · PLoS ONE
Open access |
21 Oct 2016 |
152 |
| 29 |
Chemerin Connects Fat to Arterial Contraction
Stephanie Wengert Watts, Anne McLaren Dorrance, Mark E.T. Penfold et al. · Arteriosclerosis Thrombosis and Vascular Biology
Open access |
5 Apr 2013 |
147 |
| 30 |
Functional Analysis of the Human Cytomegalovirus US28 Gene by Insertion Mutagenesis with the Green Fluorescent Protein Gene
Jeffrey Vieira, Thomas J. Schall, Lawrence Corey et al. · Journal of Virology
Open access |
Oct 1998 |
139 |
| 31 |
Fractalkine receptor expression by T lymphocyte subpopulations andin vivo production of fractalkine in human
Arnaud Foussat, Aurore Coulomb L’Herminé, Jennifa Gosling et al. · European Journal of Immunology
|
2000 |
138 |
| 32 |
A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s Disease
Satish Keshav, Tomáš Vaňásek, Yaron Niv et al. · PLoS ONE
Open access |
20 Mar 2013 |
135 |
| 33 |
Immunosuppressive Myeloid Cells Induced by Chemotherapy Attenuate Antitumor CD4+ T-Cell Responses through the PD-1–PD-L1 Axis
Zhi-Chun Ding, Xiaoyun Lu, Miao Yu et al. · Cancer Research
Open access |
29 Apr 2014 |
133 |
| 34 |
Synthesis and Biopharmaceutical Evaluation of Imatinib Analogues Featuring Unusual Structural Motifs
Kyriacos Costa Nicolaou, Dionisios Vourloumis, Sotirios M. Totokotsopoulos et al. · ChemMedChem
|
20 Nov 2015 |
132 |
| 35 |
Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
Peter A. Merkel, John L. Niles, Richard Jimenez et al. · ACR Open Rheumatology
Open access |
31 Oct 2020 |
127 |
| 36 |
Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor Cells
Ping‐Pui Wong et al. · Cell
Open access |
29 May 2020 |
112 |
| 37 |
Structural basis of ligand interaction with atypical chemokine receptor 3
Martin B Gustavsson, Liwen Wang, Noortje van Gils et al. · Nature Communications
Open access |
18 Jan 2017 |
112 |
| 38 |
CXCR4 and CCR5 Expression Delineates Targets for HIV-1 Disruption of T Cell Differentiation
Robert D. Berkowitz, Karen Beckerman, Thomas J. Schall et al. · The Journal of Immunology
Open access |
Oct 1998 |
112 |
| 39 |
C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment
Nissar Ahmad Wani, Mohd Wasim Nasser, Dinesh Kumar Ahirwar et al. · Breast Cancer Research
Open access |
29 May 2014 |
110 |
| 40 |
Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3
Michael G. Johnson et al. · Bioorganic & Medicinal Chemistry Letters
Open access |
7 Apr 2007 |
107 |
| 41 |
Neuronal expression of fractalkine in the presence and absence of inflammation
Wilhelm Schwaeble, Cordula M. Stover, Thomas J. Schall et al. · FEBS Letters
Open access |
20 Nov 1998 |
104 |
| 42 |
The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells
Brian A. Zabel, Susanna Lewén, Robert Berahovich et al. · Molecular Cancer
Open access |
14 Jun 2011 |
102 |
| 43 |
Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial
Paul Peter Tak, Andra Rodica Balanescu, Vira Tseluyko et al. · Annals of the Rheumatic Diseases
|
16 May 2012 |
101 |
| 44 |
Rapid Uptake and Degradation of CXCL12 Depend on CXCR7 Carboxyl-terminal Serine/Threonine Residues
Frauke Hoffmann, Wiebke Müller, Dagmar Schütz et al. · Journal of Biological Chemistry
Open access |
27 Jun 2012 |
101 |
| 45 |
Endothelial expression of CXCR 7 and the regulation of systemic CXCL 12 levels
Robert Berahovich, Brian A. Zabel, Susanna Lewén et al. · Immunology
Open access |
12 Oct 2013 |
98 |
| 46 |
Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan
Frank B. Cortazar et al. · Kidney International Reports
Open access251 authors |
2 Feb 2023 |
94 |
| 47 |
Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer
Nadine S. Jahchan et al. · Cell Reports
Open access |
Jul 2016 |
90 |
| 48 |
Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats
Matthew J. Walters et al. · British Journal of Cancer
Open access |
14 Jan 2014 |
90 |
| 49 |
Structures of atypical chemokine receptor 3 reveal the basis for its promiscuity and signaling bias
Yu‐Chen Yen, Christopher T. Schafer, Martin B Gustavsson et al. · Science Advances
Open access |
13 Jul 2022 |
89 |
| 50 |
Total Synthesis and Biological Evaluation of Natural and Designed Tubulysins
Kyriacos Costa Nicolaou, Jun Yin, Debashis Mandal et al. · Journal of the American Chemical Society
|
Feb 2016 |
89 |